Medigen Biotechnology (3176) — Free Cash Flow Generation Index
Medigen Biotechnology (3176) has a Free Cash Flow Generation Index of 0.94x as of December 2024. Free cash flow of NT$147.66 Million represents 1% of operating cash flow (NT$156.75 Million). Explore 3176 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Medigen Biotechnology Free Cash Flow Generation Index (2003–2024)
Historical FCF Generation Index trend for Medigen Biotechnology across 5 annual periods. For the full cash flow conversion analysis, see 3176 cash generation efficiency.
Annual Free Cash Flow Generation for Medigen Biotechnology (2003–2024)
Year-by-year Free Cash Flow Generation Index for Medigen Biotechnology. Check 3176 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.55x | NT$-20.76 Million | NT$37.92 Million | NT$58.68 Million | ▼ -176.0% |
| 2021 | 0.72x | NT$372.90 Million | NT$517.45 Million | NT$144.55 Million | ▼ -73.8% |
| 2015 | 2.75x | NT$809.42 Million | NT$294.18 Million | NT$515.25 Million | ▲ +164.6% |
| 2005 | 1.04x | NT$83.93 Million | NT$80.72 Million | NT$3.21 Million | ▲ +3.1% |
| 2003 | 1.01x | NT$449.42 Million | NT$445.46 Million | NT$3.96 Million | — |